Highest-materiality recent filing
Mitchell P. Rales appointed Executive Chair effective June 10, 2026; Rhonda Jordan named Lead Independent Director.
ESAB completes $1.45B acquisition of Eddyfi Technologies
Acquired Eddyfi for $1.45 billion in cash, subject to customary working capital adjustments.
ESAB shareholders elect nine directors, ratify EY, approve say-on-pay at 2026 annual meeting
All nine director nominees elected; Rajiv Vinnakota received 55.8M for, 1.8M against (lowest support).
ESAB Q1 record sales $746M (+10%), core adj. EPS $1.31 (+5%), reiterates FY2026 outlook
Record Q1 sales $746M (+10% reported, -1% core organic); net income $50M ($0.82 GAAP EPS).
ESAB appoints Brent Jones as CFO; reaffirms 2026 outlook
R. Brent Jones named EVP and CFO, effective early May 2026; succeeds Kevin Johnson, who resigned to pursue another opportunity.
ESAB issues $1B in 5.625% senior notes due 2031 to fund Eddyfi Technologies acquisition
Issued $1,000 million principal of 5.625% senior notes due 2031; interest semi-annual starting Oct 1, 2026.
ESAB prices $1B senior notes at 5.625% due 2031, proceeds for Eddyfi acquisition
$1.0B aggregate principal of 5.625% Senior Notes due 2031 priced; expected to close March 26, 2026.
ESAB confirms Q4 2025: sales $721M, core adj. EPS $1.35; FY2026 guidance $5.70-$5.90 EPS
Q4 sales $721M (+7% reported, -2% core organic YoY); core adj. EBITDA $140M (+9%, margin 20.4%).
ESAB acquires Eddyfi for $1.45B; reports preliminary Q4/FY2025 results and 2026 outlook
ESAB to acquire Eddyfi Technologies for $1.45B cash, expected to close mid-2026.
ESAB appoints AI expert Dr. Sébastien Martin to board; Patrick Allender to retire at 2026 meeting
Dr. Sébastien Martin appointed to ESAB board effective Jan 1, 2026; board expands from 9 to 10 members.
ESAB Q3 sales $728M (+8% reported, +2% core organic); raises FY guidance
Core adj. EBITDA $133M (+7% YoY), margin 19.4%; core adj. net income $81M ($1.32 diluted EPS).
ESAB enters $1.4B credit facility, repays existing debt, extends maturity to 2030
New $350M term loan A facility and $1.05B revolving credit facility, each maturing Oct 16, 2030.
ESAB Q2 core adjusted EBITDA margin record 20.4%; FY 2025 guidance raised
Q2 sales $716M, core organic growth -1% (reported +1%) vs prior year.
ESAB to acquire EWM GmbH for ~€275M; expands heavy industrial welding equipment
Acquisition of German-based EWM GmbH for ~€275M; EWM expected to generate ~€120M revenue in 2025.
ESAB shareholders approve amended equity plan and elect four directors at annual meeting
A&R 2022 Omnibus Incentive Plan approved: no new shares authorized; extended term, eliminated individual award limit, increased director grant cap.
ESAB Q1 sales $678M, core adj. EBITDA $128M (+4%, margin 19.8%); raises FY sales & EBITDA outlook
Q1 sales $678M (-2% reported; flat core organic growth); net income $70M ($1.14 diluted EPS).
ESAB Q4 core adj EPS $1.28; sales $671M; FY2025 adj EBITDA $515-$530M
Q4 sales $671M, flat core organic growth YoY; core adj EBITDA $129M (+2%), margin 20.3%.
ESAB Q3 core adjusted EBITDA margin expands 130bps to 19.6%; raises mid-point of FY 2024 outlook
Q3 sales $673M, core organic growth +1% YoY; net income $69M ($1.13 diluted EPS).
ESAB Corp authorizes repurchase of up to 5 million common shares
Board approved repurchase of up to 5,000,000 shares of common stock.
ESAB Q2 net income $84M, core adj EBITDA margin 20.1%, lowers full-year sales guidance
Q2 sales $707M (-2% reported, +1% core organic); core adj EBITDA $134M (+6% YoY), margin 150 bps expansion to 20.1%.
ESAB stockholders elect two Class II directors, ratify auditor, approve say-on-pay
Patrick W. Allender re-elected with 55.3M for, 350K against; Rhonda L. Jordan with 54.9M for, 720K against.
ESAB Q1 sales $690M, adj. EBITDA margin 18.8%; raises FY2024 outlook
Sales $690M (+1% reported, +2% core organic); GAAP EPS $1.00, core adj. EPS $1.20.
ESAB issues $700M of 6.25% senior notes due 2029 to repay Term Loan A-3
$700M aggregate principal, 6.25% interest semi-annual, matures April 15, 2029.
ESAB prices $700M 6.25% senior notes due 2029, upsized from initial $600M
Offering upsized to $700M aggregate principal; coupon 6.25%, maturity 2029.
ESAB Q4 2023 sales $689M, core adj EBITDA $126M (+18%); guides FY2024
Q4 sales $689M (+4% core organic growth vs prior year); net income $58M ($0.96 diluted EPS).
ESAB files 8-K/A to furnish non-GAAP reconciliations from Dec 5 2023 Investor Day
Amendment adds appendix with non-GAAP reconciliations that were missing from original 8-K filed Dec 5, 2023.
ESAB holds Investor Day on December 5, 2023; presentation contents not detailed in filing
Presentation furnished as Exhibit 99.1; live webcast available on ESAB website.
ESAB Q3 sales $681M (+10%); net income $59M; raises FY23 guidance
Q3 sales $681M (+10% reported, +7% core organic); net income $59M, diluted EPS $0.97.
ESAB Q2 2023 sales $720M (+9%); net income $67M; raises full-year guidance
Record Q2 sales of $720M (+9% reported, +6% core organic growth vs. Q2 2022).
ESAB stockholders elect three directors, ratify EY, approve say-on-pay
Class I directors elected: Mitchell P. Rales, Stephanie M. Phillipps, Didier Teirlinck; each >54.9M votes for.
ESAB Q1 sales $684M (+7% core organic), adj EBITDA $113M (+12%); raises FY outlook
Sales $684M, core organic growth 7% YoY; core adj EBITDA $113M (+12%), margin 17.4% (+80bps).
ESAB Corp announces Class I directors to stand for re-election at 2023 annual meeting
Mitchell P. Rales, Stephanie M. Phillipps, and Didier Teirlinck to stand for re-election.
ESAB Q4 2022: diluted EPS $0.97, adj. EPS $1.05; sales +11% organic; guides 2023 EBITDA $420-440M
Q4 2022 sales $664M (+6% reported, +11% organic); net income $59M.
ESAB closes secondary offering of 6M shares at $40; no proceeds to company
Goldman Sachs sold 6,003,431 ESAB shares previously owned by Enovis at $40.00 per share.
ESAB Q3 beats: core adj. EPS $0.92, raises FY core adj. EPS guidance to $4.00-$4.10
GAAP EPS $0.88, core adjusted diluted EPS $0.92; net income $53M from continuing ops.
ESAB Q2 2022: record sales $661M, adj EPS $1.14, reaffirms FY guidance
Record Q2 sales $661.2M (+9% organic); adj EBITDA $110.5M (+6% YoY).
Director Melissa Cummings appointed to ESAB Audit Committee
Melissa Cummings appointed to Audit Committee effective July 21, 2022.
ESAB refinances $600M 364-day term loan with new $600M 3-year term loan A facility
New $600M senior term loan A facility (Term A-3) matures April 3, 2025.
ESAB Q1 2022: record sales $648M, adj. EPS $1.17, reaffirms FY guidance
Sales of $647.9M, up 14% reported and 18% organic YoY; record quarterly revenue.
Spin-off completed April 4, 2022; ESAB common stock begins trading April 5 on NYSE under "ESAB".
ESAB appoints Melissa Cummings as director, effects stock split as part of Colfax separation
Melissa Cummings appointed to board effective upon completion of separation from Colfax; board expands to 10 members.
ESAB to hold investor meetings for planned separation from Colfax
Investor meetings begin March 21, 2022 in connection with anticipated separation from Colfax Corporation.
On June 10, 2026, ESAB Corporation (the “Company” or “ESAB”) appointed Mitchell P. Rales as Executive Chair of the Board of Directors (“Executive Chair”), effective as of June 10, 2026
each of Mitchell P. Rales, Melissa Cummings, Rhonda L. Jordan, Shyam P. Kambeyanda, Robert S. Lutz, Stephanie M. Phillipps, Didier Teirlinck, and Rajiv Vinnakota were appointed to the Board
each of Mitchell P. Rales, Melissa Cummings, Rhonda L. Jordan, Shyam P. Kambeyanda, Robert S. Lutz, Stephanie M. Phillipps, Didier Teirlinck, and Rajiv Vinnakota were appointed to the Board
Mr. Rales was appointed Chair of the Board effective as of the Distribution Date.
each of Mitchell P. Rales, Melissa Cummings, Rhonda L. Jordan, Shyam P. Kambeyanda, Robert S. Lutz, Stephanie M. Phillipps, Didier Teirlinck, and Rajiv Vinnakota were appointed to the Board
each of Mitchell P. Rales, Melissa Cummings, Rhonda L. Jordan, Shyam P. Kambeyanda, Robert S. Lutz, Stephanie M. Phillipps, Didier Teirlinck, and Rajiv Vinnakota were appointed to the Board
each of Mitchell P. Rales, Melissa Cummings, Rhonda L. Jordan, Shyam P. Kambeyanda, Robert S. Lutz, Stephanie M. Phillipps, Didier Teirlinck, and Rajiv Vinnakota were appointed to the Board
each of Mitchell P. Rales, Melissa Cummings, Rhonda L. Jordan, Shyam P. Kambeyanda, Robert S. Lutz, Stephanie M. Phillipps, Didier Teirlinck, and Rajiv Vinnakota were appointed to the Board
each of Mitchell P. Rales, Melissa Cummings, Rhonda L. Jordan, Shyam P. Kambeyanda, Robert S. Lutz, Stephanie M. Phillipps, Didier Teirlinck, and Rajiv Vinnakota were appointed to the Board
On March 23, 2022, the Board of Directors (the “Board”) of ESAB Corporation (the “Company” or “ESAB”) appointed Melissa Cummings to serve as a director of the Company, effective upon the consummation of the previously announced separation (the “Separation”) of the Company from Colfax Corporation (“Colfax”).
Max materiality 0.90 · Median 0.70 · Most common event earnings